Reuters logo
BRIEF-Clovis Oncology reports Q3 adjusted shr loss of $1.24
November 1, 2017 / 11:46 PM / 21 days ago

BRIEF-Clovis Oncology reports Q3 adjusted shr loss of $1.24

Nov 1 (Reuters) - Clovis Oncology Inc -

* CLOVIS ONCOLOGY ANNOUNCES THIRD QUARTER 2017 OPERATING RESULTS

* Q3 ADJUSTED LOSS PER SHARE $1.24 EXCLUDING ITEMS

* Q3 LOSS PER SHARE $1.24

* Q3 EARNINGS PER SHARE VIEW $-1.22 -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below